Grey Wolf Therapeutics
Small molecules to increase tumor detection by the immune system.
2
Funding Rounds
$99.0m
Money raised
Overview
Small molecules to increase tumor detection by the immune system.
- Website:
- Headquarters: Oxford
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Grey Wolf Therapeutics has raised a total of $99m in funding over 2 rounds.
Key Insights:
- Grey Wolf Therapeutics May 2024 Series B Funding Round: $50m
- Grey Wolf Therapeutics January 2023 Series B Funding Round: $49m
Grey Wolf Therapeutics May 2024 Series B Funding Round
$50m
Grey Wolf Therapeutics January 2023 Series B Funding Round
$49m